Ignite Creation Date:
2024-05-06 @ 4:50 PM
Last Modification Date:
2024-10-26 @ 2:16 PM
Study NCT ID:
NCT05102318
Status:
UNKNOWN
Last Update Posted:
2022-02-11
First Post:
2021-10-20
Brief Title:
Clinical and Radiographic Evaluation of Mineral Trioxide Aggregate and Biodentine as Pulp Medicaments in Primary Molars
Sponsor:
British University In Egypt
Organization:
British University In Egypt
Study Overview
Official Title:
Clinical and Radiographic Evaluation of Mineral Trioxide Aggregate and Biodentine as Pulp Medicaments in Primary Molars
Status:
UNKNOWN
Status Verified Date:
2022-01
Last Known Status:
RECRUITING
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The aim of the present study is to evaluate Mineral Trioxide Aggregate and Biodentine in direct pulp capping partial pulpotomy and pulpotomy in primary molars
Detailed Description:
Screening of patients will continue until the target population is achieved Identifying and recruiting potential subjects is achieved through patient database in Pediatric Dentistry department
A total of 150 primary molars from healthy subjects will be selected from the Pediatric Dentistry and Dental Public Health outpatient clinic Faculty of Dentistry Ain shams University
Subjects will be assigned randomly into two different treatment groups as follows
MTA Group 1
1 Group 1A MTA Direct Pulp Capping n25
2 Group 1 B MTA Partial Pulpotomy n25
3 Group 1 C MTA Complete Pulpotomy n25
BiodentineTM Group 2
1 Group 2A BiodentineTM Direct Pulp Capping n25
2 Group 2 B BiodentineTM Partial Pulpotomy n25
3 Group 2 C BiodentineTM Complete Pulpotomy n25
A total of 150 primary molars from healthy subjects will be selected from the Pediatric Dentistry and Dental Public Health outpatient clinic Faculty of Dentistry Ain shams University
Subjects will be assigned randomly into two different treatment groups as follows
MTA Group 1
1 Group 1A MTA Direct Pulp Capping n25
2 Group 1 B MTA Partial Pulpotomy n25
3 Group 1 C MTA Complete Pulpotomy n25
BiodentineTM Group 2
1 Group 2A BiodentineTM Direct Pulp Capping n25
2 Group 2 B BiodentineTM Partial Pulpotomy n25
3 Group 2 C BiodentineTM Complete Pulpotomy n25
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
True
Is an FDA AA801 Violation?:
None